Meclizine Hydrochloride
NDC 71610-526
Product Information
Meclizine Hydrochloride is a OTC MONOGRAPH FINAL-approved product labeled by Aphena Pharma Solutions - Tennessee, Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a pink product. This product entry covers the primary NDC 71610-526 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
5172
Code Structure Chart
Product Details
What is NDC 71610-526?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO)
- MECLIZINE (UNII: 3L5TQ84570) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSPOVIDONE (UNII: 2S7830E561)
- VANILLA (UNII: Q74T35078H)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- RASPBERRY (UNII: 4N14V5R27W)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 995632 - meclizine HCl 25 MG Chewable Tablet
- RxCUI: 995632 - meclizine hydrochloride 25 MG Chewable Tablet
* Please review the full disclaimer at the bottom of this page.
Patient Education
Meclizine
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
[Learn More]
* Please review the full disclaimer at the bottom of this page.